Table 2.
Treatment history for major depressive disorder
Treatment for current MDD episode | ||
---|---|---|
Prior to visita | Baseline | Month 6 |
N = 613 | N = 613 | |
Any treatment (n) | 589 (96.1 %) | NA |
Psychotherapy | 29 (4.9 %) | NA |
Tricyclic antidepressants | 19 (3.2 %) | NA |
SSRI | 303 (51.4 %) | NA |
SNRI | 202 (34.3 %) | NA |
Antipsychotics | 0 (0.0 %) | NA |
Mood stabilizers | 4 (0.7 %) | NA |
Light therapy, ECT, or herbal remedies | 0 | NA |
Other | 32 (5.4 %) | NA |
At visitb | Baseline | Month 6 |
Any treatment (n) | 474 (77.3 %) | 377 (61.5 %) |
Psychotherapy | 22 (4.6 %) | 14 (3.7 %) |
Tricyclic antidepressants | 15 (3.2 %) | 15 (4.0 %) |
SSRI | 225 (47.5 %) | 168 (44.6 %) |
SNRI | 182 (38.4 %) | 154 (40.8 %) |
Antipsychotics | 2 (0.4 %) | 2 (0.5 %) |
Mood stabilizers | 4 (0.8 %) | 6 (1.6 %) |
Light therapy, ECT, or herbal remedies | 0 | 0 |
Other | 24 (5.1 %) | 18 (4.8 %) |
Abbreviations: ECT, electroconvulsive therapy, MDD major depressive disorder, N number of patients involved in the summary, n number of patients in the given category, NA not applicable, SNRI serotonin norepinephrine reuptake inhibitors, SSRI selective serotonin reuptake inhibitors
aApart from the row, ‘Any treatment’, all other percentages in ‘Prior to visit’ section use. n = 589 (n of patients with any treatment) as denominator
bApart from the row, ‘Any treatment’, all other percentages in ‘At visit’ section use. n = 474 (n of patients with any treatment) as denominator